SEC ownership of NEOGENOMICS INC

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001077183.

Comparable stake leader

BlackRock, Inc.

Disclosed value leader

BlackRock, Inc.

Comparable rows

50/50

Latest evidence

30 Apr 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 2 signals
Latest 13D/G holder
BlackRock, Inc.
Latest parsed ownership date
30 Apr 2026
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001077183
Issuer location
Fort Myers, FL

Ownership snapshot

Top shareholders of NEOGENOMICS INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
30 Apr 2026
13F 13D/G Lead comparable stake: 15% 13D/G row: BlackRock, Inc. Showing 1-8 of 50 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 15%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 15%
First Light Asset Management, LLC 11%
Greenhouse Funds LLLP 7.1%
VANGUARD PORTFOLIO MANAGEMENT LLC 5.9%
VANGUARD CAPITAL MANAGEMENT LLC 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
15%
from 13D/G
$148,084,663
19,957,502 shares
31 Mar 2026
First Light Asset Management, LLC
13D/G 13F
Mathew P. Arens · Company
11%
$115,847,880
14,093,416 shares
+$35,417,243 30 Apr 2026
Greenhouse Funds LLLP
13D/G 13F
Company
7.1%
$75,754,723
9,215,903 shares
+$14,670,694 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC
13D/G 13F
Vanguard Portfolio Management · Company
5.9%
$56,969,231
7,677,794 shares
$0 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
5.1%
$49,048,218
6,610,272 shares
$0 31 Mar 2026
JANUS HENDERSON GROUP PLC
13D/G 13F
Company
4.8%
$63,315,197
6,165,063 shares
$0 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
Millennium Management LLC
2.8%
$26,073,366
3,566,808 shares
-$24,761,251 30 Jun 2025
T. Rowe Price Investment Management, Inc.
13D/G
2.6%
$34,067,326
3,317,169 shares
$0 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$364,578.

Buys
$212,276
Insiders: 2
Sells
$576,854
Insiders: 2
Net
-$364,578
Shares: -10,062
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 37,900 Shares: 47,962
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 22,128 $0 $276,682 -$276,682
6-9 0 25,834 $0 $300,172 -$300,172
9-12 37,900 0 $212,276 $0 +$212,276

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 37 reporting-owner rows connected to NEOGENOMICS INC. Open a relationship link for the CIK-to-CIK filing trail.

Rows
37
Largest Forms 3/4/5 holder
Douglas M. van Oort
Net 12M change
-$364,578
Latest report
01 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Douglas M. van Oort Director $45,677,027 Mixed 01 Aug 2021
Christopher M. Smith Chief Executive Officer $15,690,205 Mixed 23 Feb 2025
Anthony P. Zook Chief Executive Officer, Director $9,421,907 +$99,954 +1.1% Mixed 01 Apr 2026
Mark Mallon Chief Executive Officer, Director $6,768,458 Mixed 01 Mar 2022
Jeffrey Scott Sherman Chief Financial Officer $6,163,431 +$112,322 +1.9% Mixed 21 Feb 2026
George Cardoza President & COO, Lab Ops $4,857,847 Mixed 01 Mar 2022
William Bonello Chief Financial Officer $3,522,568 Mixed 28 Apr 2022
Warren Stone Pres & Chief Operating Officer $3,478,183 -$276,682 -7.4% Mixed 11 May 2026
Douglas Matthew Brown Chief Strategy Officer $2,918,199 Mixed 01 Apr 2022
Robert J. Shovlin President, Clinical Services $2,760,357 Mixed 25 May 2021
Halley E. Gilbert Chief Legal Officer $2,710,612 Mixed 01 Mar 2022
Vishal Sikri President Advanced Diagnostics $2,687,306 Mixed 23 Feb 2024
Melody Harris Chf Ops Off, Pres, Informatics $2,353,925 Mixed 21 Feb 2025
Alicia C. Olivo EVP, GC & Business Development $2,138,461 -$300,172 -12% Mixed 11 May 2026
Shashikant Kulkarni Chief Scientific Officer $1,520,356 Mixed 01 Apr 2023
Bruce K. Crowther Director $1,406,026 Mixed 10 Aug 2023
Alison L. Hannah Director $1,201,755 Mixed 01 Jun 2025
Lynn A. Tetrault Director $1,147,322 Mixed 01 Jun 2026
Michael Aaron Kelly Director $942,665 Mixed 01 Jun 2026
Stephen M. Kanovsky Director $937,276 Mixed 01 Jun 2026

Recent insider transactions for NEOGENOMICS INC

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
John P. Kenny NEO Common Stock Options Exercise 5,893 5,893 01 Jun 2026 Direct
John P. Kenny NEO Restricted Stock Unit Award 15,970 15,970 01 Jun 2026 Direct
John P. Kenny NEO Stock Option (Right to Buy) Award 11,069 11,069 01 Jun 2026 Direct
John P. Kenny NEO Restricted Stock Unit Options Exercise -100% -5,893 0 01 Jun 2026 Direct
Felicia Williams NEO Common Stock Options Exercise 322.3% 23,077 30,237 01 Jun 2026 Direct
Felicia Williams NEO Restricted Stock Unit Award 15,970 15,970 01 Jun 2026 Direct
Felicia Williams NEO Stock Option (Right to Buy) Award 11,069 11,069 01 Jun 2026 Direct
Felicia Williams NEO Restricted Stock Unit Options Exercise -100% -23,077 0 01 Jun 2026 Direct
Lynn A. Tetrault NEO Common Stock Options Exercise 31.3% 23,077 96,729 01 Jun 2026 Direct
Lynn A. Tetrault NEO Restricted Stock Unit Award 15,970 15,970 01 Jun 2026 Direct
Lynn A. Tetrault NEO Stock Option (Right to Buy) Award 11,069 11,069 01 Jun 2026 Direct
Lynn A. Tetrault NEO Restricted Stock Unit Options Exercise -100% -23,077 0 01 Jun 2026 Direct
David Brian Perez NEO Common Stock Options Exercise 68.1% 23,077 56,967 01 Jun 2026 Direct
David Brian Perez NEO Restricted Stock Unit Award 15,970 15,970 01 Jun 2026 Direct
David Brian Perez NEO Stock Option (Right to Buy) Award 11,069 11,069 01 Jun 2026 Direct
David Brian Perez NEO Restricted Stock Unit Options Exercise -100% -23,077 0 01 Jun 2026 Direct
Michael Aaron Kelly NEO Common Stock Options Exercise 52.4% 23,077 67,086 01 Jun 2026 Direct
Michael Aaron Kelly NEO Restricted Stock Unit Award 15,970 15,970 01 Jun 2026 Direct
Michael Aaron Kelly NEO Stock Option (Right to Buy) Award 11,069 11,069 01 Jun 2026 Direct
Michael Aaron Kelly NEO Restricted Stock Unit Options Exercise -100% -23,077 0 01 Jun 2026 Direct
Stephen M. Kanovsky NEO Common Stock Options Exercise 44.1% 23,077 75,421 01 Jun 2026 Direct
Stephen M. Kanovsky NEO Restricted Stock Unit Award 15,970 15,970 01 Jun 2026 Direct
Stephen M. Kanovsky NEO Stock Option (Right to Buy) Award 11,069 11,069 01 Jun 2026 Direct
Stephen M. Kanovsky NEO Restricted Stock Unit Options Exercise -100% -23,077 0 01 Jun 2026 Direct
Neil Gunn NEO Common Stock Options Exercise 82.1% 23,077 51,177 01 Jun 2026 Direct
Neil Gunn NEO Restricted Stock Unit Award 15,970 15,970 01 Jun 2026 Direct
Neil Gunn NEO Stock Option (Right to Buy) Award 11,069 11,069 01 Jun 2026 Direct
Neil Gunn NEO Restricted Stock Unit Options Exercise -100% -23,077 0 01 Jun 2026 Direct
Marjorie C. Green NEO Common Stock Options Exercise 22,964 22,964 01 Jun 2026 Direct
Marjorie C. Green NEO Restricted Stock Unit Award 15,970 15,970 01 Jun 2026 Direct
Marjorie C. Green NEO Stock Option (Right to Buy) Award 11,069 11,069 01 Jun 2026 Direct
Marjorie C. Green NEO Restricted Stock Unit Options Exercise -100% -22,964 0 01 Jun 2026 Direct
Alicia C. Olivo NEO Common Stock Tax liability -2.66% -2,559 93,567 11 May 2026 Direct
Alicia C. Olivo NEO Common Stock Options Exercise 4.28% 3,944 96,126 11 May 2026 Direct
Alicia C. Olivo NEO Restricted Stock Unit Options Exercise -60.6% -3,944 2,559 11 May 2026 Direct
Warren Stone NEO Common Stock Tax liability -2.25% -3,783 164,032 11 May 2026 Direct
Warren Stone NEO Common Stock Options Exercise 3.6% 5,830 167,815 11 May 2026 Direct
Warren Stone NEO Restricted Stock Unit Options Exercise -60.6% -5,830 3,783 11 May 2026 Direct
Greg D. Aunan NEO Common Stock Tax liability -4.95% -1,309 25,153 02 May 2026 Direct
Greg D. Aunan NEO Common Stock Options Exercise 25.5% 5,372 26,462 02 May 2026 Direct
Greg D. Aunan NEO Restricted Stock Unit Options Exercise -33.3% -5,372 10,745 02 May 2026 Direct
Warren Stone NEO Common Stock Tax liability -1.43% -2,349 161,985 02 May 2026 Direct
Warren Stone NEO Common Stock Options Exercise 3.77% 5,969 164,334 02 May 2026 Direct
Warren Stone NEO Restricted Stock Unit Options Exercise -33.3% -5,969 11,939 02 May 2026 Direct
Greg D. Aunan NEO Common Stock Tax liability -4.25% -937 21,090 01 May 2026 Direct
Alicia C. Olivo NEO Common Stock Tax liability -1.12% -1,042 92,182 01 May 2026 Direct
Warren Stone NEO Common Stock Tax liability -4.18% -6,911 158,365 01 Apr 2026 Direct
Warren Stone NEO Common Stock Options Exercise 11.9% 17,562 165,276 01 Apr 2026 Direct
Warren Stone NEO Restricted Stock Unit Options Exercise -33.3% -17,562 35,125 01 Apr 2026 Direct
Anthony P. Zook NEO Common Stock Tax liability -25.4% -45,453 133,111 01 Apr 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .